
What’s Next For Cannabis Rescheduling After Shock Delay?
The rescheduling of cannabis in the US, one of the most consequential cannabis reform efforts of the last century, is

The rescheduling of cannabis in the US, one of the most consequential cannabis reform efforts of the last century, is

The highly anticipated hearings on cannabis rescheduling, set to begin next week, have now been cancelled in a major escalation of tensions between the Drug Enforcement Administration (DEA) and other witnesses.

Cannabis stocks plummeted this week after a judge ordered the Drug Enforcement Agency (DEA) to respond to damning new allegations

Reaching consensus on hotly debated issues is rare in the cannabis space, especially when it comes to potential ramifications of

The Drug Enforcement Administration (DEA) has scheduled an official date for the highly anticipated public hearing on cannabis rescheduling, starting with a presentation from the government just a day after President Elect Donald Trump is sworn in.

The first step in the US’s landmark efforts to reschedule cannabis officially took place yesterday, setting the stage for what is set to be a lively and heated process.

Following the short-lived candidacy of Matt Gaetz for US Attorney General in President elect Donald Trumps new cabinet, the outlooks

Ahead of the delayed and highly anticipated cannabis rescheduling hearings, now set to take place in early 2025, the US Drug Enforcement Administration (DEA) has suggested it could add more participants.

The next step in the yearslong cannabis rescheduling process could be a brief hearing where an administrative law judge informs witnesses why they aren’t qualified to participate, observers told MJBizDaily.

Written by Deb Tharp, activist and political consultant. We were on the cusp of full federal recognition of medical cannabis.

As the most consequential US election in recent history comes to close after a long and turbulent campaign, the dust is beginning to settle on the prospective outlook for cannabis under the new administration.

Ahead of the upcoming public hearing on cannabis rescheduling in the US, the American Institute of Certified Public Accountants (AICPA) has called on the Treasury Department to update tax guidelines for cannabis businesses.

Writing for Business of Cannabis, Deborah Tharp, a cannabis-focused political consultant, campaign manager and legal researcher for Nugg and NuggMD, explains why it’s more crucial than ever not to overlook the stark differences between medical and recreational cannabis use.

Vice President Kamala Harris has reaffirmed her support for legalizing cannabis, discussing the issue publicly for the first time since

US President Joe Biden has conceded that cannabis rescheduling is not yet a done deal, and is now almost certain

As Vice President Kamala Harris’s poll lead begins to dwindle, former President Donald Trump has taken to espousing uncharacteristically liberal

News that the US Drug Enforcement Administration (DEA) is set to host a public administrative hearing on cannabis rescheduling has

The US Department of Health and Human Services (HHS) has officially completed its report into the state of cannabis research